表紙
市場調査レポート

心血管インターベンション装置および末梢血管装置の世界市場予測 2019年:バルーン・ステント・カテーテル・IVCフィルター

Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019

発行 MarketsandMarkets 商品コード 247573
出版日 ページ情報 英文 235 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
心血管インターベンション装置および末梢血管装置の世界市場予測 2019年:バルーン・ステント・カテーテル・IVCフィルター Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessories) - Forecasts to 2019
出版日: 2015年06月03日 ページ情報: 英文 235 Pages
概要

世界の心血管インターベンション・末梢血管装置市場は、2014年の187億3,000万米ドルから2019年までに267億2,000万米ドルへと7.4%のCAGRで成長する見込みです。同市場の主な促進因子として、高齢者人口の増加、心血管疾患の発症率の増加、低侵襲処置需要の増加、および技術進歩が挙げられます。さらに、インドや中国と言った新興経済国は心血管インターベンション・末梢血管装置市場へ成長のチャンスを提示しています。しかし、製品の不具合や小規模企業にとっての参入障壁は、同市場の成長を抑制すると予測されています。

当レポートでは、世界の心血管インターベンション・末梢血管装置市場について調査し、市場概要、製品・地域別の市場分析、競合環境の分析、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 心血管インターベンション・末梢血管装置:市場分析
  • 血管形成ステント
  • 心血管インターベンション・末梢血管装置:地域別
  • プラーク修飾装置市場:種類別
  • 血流改変装置市場:種類別
  • カテーテル市場:種類別
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 血管形成術用バルーン市場:種類別
    • 血管形成術用ステント市場:種類別
    • カテーテル市場:種類別
    • 血管内動脈瘤修復ステントグラフト市場 (EVARステントグラフト) :種類別
    • 下大静脈フィルター市場 (IVCフィルター):種類別
    • プラーク修飾装置市場:種類別
    • 血流改変装置市場:種類別
    • 付属品市場:種類別
    • 心血管インターベンション・末梢血管装置:地域別
  • 市場動態
    • 推進要因
    • 抑制要因
    • 機会
    • 課題

第6章 産業考察

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 認可済み心血管インターベンション・末梢血管装置

第7章 血管形成術市場規模:処置種類別

  • イントロダクション
  • 経皮的バルーン血管形成術 (POBA)
  • 経皮経管冠動脈形成術 (PTCA)
  • 経皮経管的血管形成術 (PTA)

第8章 血管形成術用バルーン市場:種類別

  • イントロダクション
  • 血管形成術用バルーン市場:種類別
  • 血管形成術用バルーン材料
  • 血管形成術用バルーンプラットフォーム

第9章 血管形成術用ステント市場:種類別

  • イントロダクション
  • 血管形成術用ステント:種類別
  • 血管形成術用ステント:デリバリープラットフォーム別

第10章 カテーテル市場:種類別

  • イントロダクション
  • ガイディングカテーテル市場
  • 血管形成術用カテーテル市場
  • 血管内超音波カテーテル (IVUSカテーテル) /光コヒーレンストモグラフィーカテーテル (OCTカテーテル) 市場

第11章 血管内動脈瘤修復 (EVAR) ステントグラフト市場:種類別

  • イントロダクション
  • 腹部大動脈瘤
  • 胸部大動脈瘤

第12章 下大静脈 (IVC) フィルター市場:種類別

  • イントロダクション
  • 永久留置型フィルター
  • 回収可能型フィルター

第13章 プラーク修飾装置

  • イントロダクション
  • 血栓切除装置

第14章 血流改変装置

  • イントロダクション
  • 塞栓保護装置

第15章 付属品

  • イントロダクション
  • 血管閉鎖装置 (VCD)
  • イントロデューサシース
  • ガイドワイヤー
  • バルーン拡張装置

第16章 地域別分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他の地域 (ROW)

第17章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向

第18章 企業プロファイル

  • イントロダクション
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C.R. Bard
  • Cordis Corporation (A Subsidiary of Johnson & Johnson Co.)
  • Medtronic, Inc.
  • Spectranetics International BV
  • St. Jude Medical, Inc.
  • Terumo Corporation
  • Volcano Corporation

第19章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3456

The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 billion by 2019 from $18.73 billion in 2014, at a CAGR of 7.4%. The global interventional cardiology and peripheral vascular devices market is segmented based on products and geography. Based on products, the market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories.

The angioplasty stents segment accounted for the largest share of the interventional cardiology and peripheral vascular devices market during the forecast period. The large share of this segment is attributed to the rising prevalence of cardiovascular diseases and increasing initiatives by companies for developing new and technologically advanced stents for better clinical outcomes.

Major factors contributing to the growth of the interventional cardiology and peripheral vascular devices market include rising aging population, increasing demand of minimally invasive procedures, rising incidence of cardiovascular diseases, and technological advancements. According to the World Health Organization, in 2012, 17.5 million people died due to CVDs; this figure accounted for 31% of the global deaths in 2012. Furthermore, in the same year, 16 million people aged below 70 years died due to non-communicable diseases; of this, 37% deaths were related to CVDs. Emerging markets in Asia have opened an array of opportunities for the growth of the interventional cardiology and peripheral vascular devices market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful in the market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of the top players in the interventional cardiology and peripheral vascular devices market. The report analyzes the interventional cardiology and peripheral vascular devices market by product and geography
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the interventional cardiology and peripheral vascular devices market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the interventional cardiology and peripheral vascular devices market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various devices across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the interventional cardiology and peripheral vascular devices market

Table of Contents

1 Introduction

  • 1.1 Objectives of the Study
  • 1.2 Market Definition
  • 1.3 Market Scope
    • 1.3.1 Market Segmentation
    • 1.3.2 Years Considered for the Study
  • 1.4 Currency
  • 1.5 Limitation
  • 1.6 Market Stakeholders

2 Research Methodology

  • 2.1 Market Size Estimation
  • 2.2 Market Breakdown and Data Triangulation
  • 2.3 Market Share Estimation
  • 2.4 Key Data From Secondary Sources
  • 2.5 Key Data From Primary Sources
  • 2.6 Key Industry Insights
  • 2.7 Assumptions for the Study

3 Executive Summary

4 Premium Insights

  • 4.1 Interventional Cardiology and Peripheral Vascular Devices: Market Opportunities
  • 4.2 Angioplasty Stents Market, By Type
  • 4.3 Interventional Cardiology and Peripheral Vascular Devices Market, By Region
  • 4.4 Plaque Modification Devices Market, By Type
  • 4.5 Hemodynamic Flow Alteration Devices Market, By Type
  • 4.6 Catheters Market, By Type
  • 4.7 Lifecycle Analysis, By Region

5 Market Overview

  • 5.1 Introduction
  • 5.2 Market Segmentation
    • 5.2.1 Angioplasty Balloons Market, By Type
    • 5.2.2 Angioplasty Stents Market, By Type
    • 5.2.3 Catheters Market, By Type
    • 5.2.4 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type
    • 5.2.5 Inferior Vena Cava Filters (IVC) Market, By Type
    • 5.2.6 Plaque Modification Devices Market, By Type
    • 5.2.7 Hemodynamic Flow Alteration Devices Market, By Type
    • 5.2.8 Accessory Devices Market, By Type
    • 5.2.9 Interventional Cardiology and Peripheral Vascular Devices Market, By Region
  • 5.3 Market Dynamics
    • 5.3.1 Drivers
    • 5.3.1.1 Growth in Aging Population
    • 5.3.1.2 Increasing Demand for Minimally Invasive Angioplasty Procedures
    • 5.3.1.3 Technological Advancements in Interventional Cardiology and Peripheral Vascular Devices
    • 5.3.2 Restraints
    • 5.3.2.1 Availability of Effective Conventional First-Level Medication
    • 5.3.2.2 Product Failure and Product Recall
    • 5.3.3 Opportunities
    • 5.3.3.1 Bioabsorbable Stents
    • 5.3.3.2 Emerging Markets
    • 5.3.4 Challenges
    • 5.3.4.1 Varying Reimbursements
    • 5.3.4.2 Entry Barriers for New Players

6 Industry Insights

  • 6.1 Porter's Five Forces Analysis
    • 6.1.1 Threat of New Entrants
    • 6.1.2 Bargaining Power of Suppliers
    • 6.1.3 Bargaining Power of Buyers
    • 6.1.4 Intensity of Competitive Rivalry
    • 6.1.5 Threat of Substitutes
  • 6.2 Supply Chain Analysis
  • 6.3 Approved Interventional Cardiology and Peripheral Vascular Devices Products

7 Angioplasty Market Size, By Type of Procedure

  • 7.2 Introduction
  • 7.3 Plain Old Balloon Angioplasty (POBA)
  • 7.4 Percutaneous Transluminal Coronary Angioplasty (PTCA)
  • 7.5 Percutaneous Transluminal Angioplasty (PTA)

8 Angioplasty Balloons Market, By Type

  • 8.1 Introduction
  • 8.2 Angioplasty Balloons Market, By Type
    • 8.2.1 Old/Normal Balloons
    • 8.2.2 Cutting and Scoring Balloons
    • 8.2.3 Drug-Eluting Balloons
  • 8.3 Angioplasty Balloon Material
    • 8.3.1 Non-Compliant Balloons
    • 8.3.2 Semi-Compliant Balloons
    • 8.3.3 Low-Compliant Balloons
  • 8.4 Angioplasty Balloon Platforms
    • 8.4.1 Over-The-Wire (OTW) Balloon Catheters
    • 8.4.2 Rapid-Exchange (RX) Balloon Catheters
    • 8.4.3 Fixed-Wire Balloon Catheters

9 Angioplasty Stents Market, By Type

  • 9.1 Introduction
  • 9.2 Angioplasty Stents, By Type
    • 9.2.1 Bare-Metal Stents
    • 9.2.2 Drug-Eluting Stents
    • 9.2.3 Bioabsorbable Stents
  • 9.3 Angioplasty Stents, By Delivery Platform
    • 9.3.1 Self-Expanding Stents
    • 9.3.2 Balloon-Expandable Stents

10 Catheters Market, By Type

  • 10.1 Introduction
  • 10.2 Guiding Catheters
  • 10.3 Angiography Catheters
  • 10.4 Intravascular Ultrasound (IVUS) Catheters/Optical Coherence Tomography (OCT) Catheters

11 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type

  • 11.1 Introduction
  • 11.2 Abdominal Aortic Aneurysms
  • 11.3 Thoracic Aortic Aneurysms

12 Inferior Vena Cava (IVC) Filters Market, By Type

  • 12.1 Introduction
  • 12.2 Permanent Filters
  • 12.3 Retrievable Filters

13 Plaque Modification Devices Market, By Type

  • 13.1 Introduction
  • 13.2 Thrombectomy Devices

14 Hemodynamic Flow Alteration Devices Market, By Type

  • 14.1 Introduction
  • 14.2 Embolic Protection Devices

15 Accessories Market, By Type

  • 15.1 Introduction
  • 15.2 Vascular Closure Devices (VCDS)
  • 15.3 Introducer Sheaths
  • 15.4 Guide Wires
  • 15.5 Balloon Inflation Devices

16 Interventional Cardiology and Peripheral Vascular Devices Market, By Region

  • 16.1 Introduction
  • 16.2 North America
    • 16.2.1 U.S.
    • 16.2.2 Canada
  • 16.3 Europe
  • 16.4 Asia
  • 16.5 RoW

17 Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Competitive Situation and Trends
    • 17.3.1 Regulatory Approvals
    • 17.3.2 Acquisitions
    • 17.3.3 New Product Launches
    • 17.3.4 Agreements, Partnerships, and Collaborations
    • 17.3.5 Other Developments

18 Company Profiles

  • 18.1 Introduction
  • 18.2 Abbott Laboratories
    • 18.2.1 Business Overview
    • 18.2.2 Product Portfolio
    • 18.2.3 Recent Developments
    • 18.2.4 MnM View
  • 18.3 B. Braun Melsungen AG
    • 18.3.1 Business Overview
    • 18.3.2 Product Portfolio
    • 18.3.3 Recent Developments
  • 18.4 Boston Scientific Corporation
    • 18.4.1 Business Overview
    • 18.4.2 Product Portfolio
    • 18.4.3 Recent Developments
    • 18.4.4 MnM View
  • 18.5 C.R. Bard
    • 18.5.1 Business Overview
    • 18.5.2 Product Portfolio
    • 18.5.3 Recent Developments
  • 18.6 Cordis Corporation (A Subsidiary of Johnson & Johnson Co.)
    • 18.6.1 Business Overview
    • 18.6.2 Product Portfolio
    • 18.6.3 Recent Developments
  • 18.7 Medtronic, Inc.
    • 18.7.1 Business Overview
    • 18.7.2 Product Portfolio
    • 18.7.3 Recent Developments
    • 18.7.4 MnM View
  • 18.8 Spectranetics International BV
    • 18.8.1 Business Overview
    • 18.8.2 Product Portfolio
    • 18.8.3 Recent Developments
  • 18.9 St. Jude Medical, Inc.
    • 18.9.1 Business Overview
    • 18.9.2 Product Portfolio
    • 18.9.3 Recent Development
  • 18.10 Terumo Corporation
    • 18.10.1 Business Overview
    • 18.10.2 Product Portfolio
    • 18.10.3 Recent Developments
  • 18.11 Volcano Corporation
    • 18.11.1 Business Overview
    • 18.11.2 Product Portfolio
    • 18.11.3 Recent Developments

19 Appendix

  • 19.1 Insights From Industry Experts
  • 19.2 Discussion Guide
  • 19.3 Available Customizations
  • 19.4 Introducing RT: Real-Time Market Intelligence
  • 19.5 Related Reports

List of Tables

  • Table 1 Technological Advancements to Boost the Market Growth for Interventional Cardiology and Peripheral Vascular Devices
  • Table 2 Availability of Effective Conventional First-Level Medication to Limit the Market Growth for Interventional Cardiology and Peripheral Vascular Devices
  • Table 3 Growth Prospects in Emerging Countries to Fuel Market Growth
  • Table 4 Irregular Reimbursement: A Major Challenge in the Interventional Cardiology and Peripheral Vascular Devices Market
  • Table 5 List of U.S. Fda Approved Products
  • Table 6 List of CE-Marked Products
  • Table 7 Angioplasty Market Size, By Type, 2012-2019 (No. of Procedures)
  • Table 8 Angioplasty Market Size, By Region, 2012-2019 (No. of Procedures)
  • Table 9 Percutaneous Transluminal Coronary Angioplasty Market Size, By Region, 2012-2019 (No. of Procedures)
  • Table 10 Percutaneous Transluminal Angioplasty Market Size, By Region, 2012-2019 (No. of Procedures)
  • Table 11 Angioplasty Balloons Market Size, By Type, 2012-2019 ($Million)
  • Table 12 Angioplasty Balloons Market Size, By Region, 2012-2019 ($Million)
  • Table 13 North America: Angioplasty Balloons Market Size, By Country, 2012-2019 ($Million)
  • Table 14 Old/Normal Angioplasty Balloons Market Size, By Region, 2012-2019 ($Million)
  • Table 15 North America: Old/Normal Angioplasty Balloons Market Size, By Country, 2012-2019 ($Million)
  • Table 16 Cutting & Scoring Angioplasty Balloons Market Size, By Region, 2012-2019 ($Million)
  • Table 17 North America: Cutting & Scoring Angioplasty Balloons Market Size, By Country, 2012-2019 ($Million)
  • Table 18 Drug-Eluting Angioplasty Balloons Market Size, By Region, 2012-2019 ($Million)
  • Table 19 North America: Drug-Eluting Angioplasty Balloons Market Size, By Country, 2012-2019 ($Million)
  • Table 20 Angioplasty Stents Market Size, By Type, 2012-2019 ($Million)
  • Table 21 Angioplasty Stents Market Size, By Region, 2012-2019 ($Million)
  • Table 22 North America: Angioplasty Stents Market Size, By Country, 2012-2019 ($Million)
  • Table 23 Bare-Metal Angioplasty Stents Market Size, By Region,2012-2019 ($Million)
  • Table 24 North America: Bare-Metal Angioplasty Stents Market Size, By Country, 2012-2019 ($Million)
  • Table 25 Drug-Eluting Angioplasty Stents Market Size, By Region, 2012-2019 ($Million)
  • Table 26 North America: Drug-Eluting Angioplasty Stents Market Size, By Country, 2012-2019 ($Million)
  • Table 27 Bioabsorbable Angioplasty Stents Market Size, By Region, 2012-2019 ($Million)
  • Table 28 North America: Bioabsorbable Angioplasty Stents Market Size, By Country, 2012-2019 ($Million)
  • Table 29 Catheters Market Size, By Type, 2012-2019 ($Million)
  • Table 30 Catheters Market Size, By Region, 2012-2019 ($Million)
  • Table 31 North America: Catheters Market Size, By Country,2012-2019 ($Million)
  • Table 32 Guiding Catheters Market Size, By Region, 2012-2019 ($Million)
  • Table 33 Guiding Catheters Market Size, By Region, 2012-2019 (Thousand Units)
  • Table 34 North America: Guiding Catheters Market Size, By Country, 2012-2019 ($Million)
  • Table 35 Angiography Catheters Market Size, By Region, 2012-2019 ($Million)
  • Table 36 North America: Angiography Catheters Market Size, By Country, 2012-2019 ($Million)
  • Table 37 IVUS/OCT Catheters Market Size, By Region, 2012-2019 ($Million)
  • Table 38 IVUS/OCT Catheters Market Size, By Region, 2012-2019 (Thousand Units)
  • Table 39 North America: IVUS/OCT Catheters Market Size, By Country, 2012-2019 ($Million)
  • Table 40 EVAR Stent Grafts Market Size, By Type, 2012-2019 ($Million)
  • Table 41 EVAR Stent Grafts Market Size, By Region, 2012-2019 ($Million)
  • Table 42 EVAR Stent Grafts Market Size, By Type, 2012-2019 (No. of Procedures)
  • Table 43 EVAR Stent Grafts Market Size, By Region, 2012-2019 (No. of Procedures)
  • Table 44 North America: EVAR Stent Grafts Market Size, By Country, 2012-2019 ($Million)
  • Table 45 EVAR Stent Grafts Market Size for Abdominal Aortic Aneurysms, By Region, 2012-2019 ($Million)
  • Table 46 EVAR Stent Grafts Market Size for Abdominal Aortic Aneurysms, By Region, 2012-2019 (No. of Procedures)
  • Table 47 North America: EVAR Stent Grafts Market Size for Abdominal Aortic Aneurysms, By Country, 2012-2019 ($Million)
  • Table 48 EVAR Stent Grafts Market Size for Thoracic Aortic Aneurysms, By Region, 2012-2019 ($Million)
  • Table 49 EVAR Stent Grafts Market Size for Thoracic Aortic Aneurysms, By Region, 2012-2019 (No. of Procedures)
  • Table 50 North America: EVAR Stent Grafts Market Size for Thoracic Aortic Aneurysms, By Country, 2012-2019 ($Million)
  • Table 51 IVC Filters Market Size, By Type, 2012-2019 ($Million)
  • Table 52 IVC Filters Market Size, By Region, 2012-2019 ($Million)
  • Table 53 IVC Filters Market Size, By Type, 2012-2019 (No. of Units)
  • Table 54 IVC Filters Market Size, By Region, 2012-2019 (No. of Units)
  • Table 55 North America: IVC Filters Market Size, By Country,2012-2019 ($Million)
  • Table 56 IVC Filters Market Size for Permanent Filters, By Region, 2012-2019 ($Million)
  • Table 57 IVC Filters Market Size for Permanent Filters, By Region, 2012-2019 (No. of Units)
  • Table 58 North America: IVC Filters Market Size for Permanent Filters, By Country, 2012-2019 ($Million)
  • Table 59 IVC Filters Market Size for Retrievable Filters, By Region, 2012-2019 ($Million)
  • Table 60 IVC Filters Market Size for Retrievable Filters, By Region, 2012-2019 (No. of Units)
  • Table 61 North America: IVC Filters Market Size for Retrievable Filters, By Country, 2012-2019 ($Million)
  • Table 62 Plaque Modification Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 63 Plaque Modification Devices Market Size, By Region,2012-2019 ($Million)
  • Table 64 North America: Plaque Modification Devices Market Size, By Country, 2012-2019 ($Million)
  • Table 65 Plaque Modification Devices Market Size for Thrombectomy Devices, By Region, 2012-2019 ($Million)
  • Table 66 North America: Plaque Modification Devices Market Size for Thrombectomy Devices, By Country, 2012-2019 ($Million)
  • Table 67 Plaque Modification Devices Market Size for Atherectomy Devices, By Region, 2012-2019 ($Million)
  • Table 68 North America: Plaque Modification Devices Market Size for Atherectomy Devices, By Country, 2012-2019 ($Million)
  • Table 69 Hemodynamic Flow Alteration Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 70 Hemodynamic Flow Alteration Devices Market Size, By Region, 2012-2019 ($Million)
  • Table 71 North America: Hemodynamic Flow Alteration Devices Market Size, By Country, 2012-2019 ($Million)
  • Table 72 Embolic Protection Devices Market Size, By Region,2012-2019 ($Million)
  • Table 73 North America: Embolic Protection Devices Market Size, By Country, 2012-2019 ($Million)
  • Table 74 Chronic Total Occlusion Devices Market Size, By Region,2012-2019 ($Million)
  • Table 75 North America: Chronic Total Occlusion Devices Market Size, By Country, 2012-2019 ($Million)
  • Table 76 Accessories Market Size, By Type, 2012-2019 ($Million)
  • Table 77 Accessories Market Size, By Region, 2012-2019 ($Million)
  • Table 78 Accessories Market Size, By Type, 2012-2019 (No. of Thousand Units)
  • Table 79 North America: Accessories Market Size, By Country,2012-2019 ($Million)
  • Table 80 Accessories Market Size for Vascular Closure Devices, By Region, 2012-2019 ($Million)
  • Table 81 Accessories Market Size for Vascular Closure Devices, By Region, 2012-2019 (No. of Thousand Units)
  • Table 82 North America: Accessories Market Size for Vascular Closure Devices, By Country, 2012-2019 ($Million)
  • Table 83 Accessories Market Size for Introducer Sheaths, By Region, 2012-2019 ($Million)
  • Table 84 Accessories Market Size for Introducer Sheaths, By Region, 2012-2019 (No. of Thousand Units)
  • Table 85 North America: Accessories Market Size for Introducer Sheaths, By Country, 2012-2019 ($Million)
  • Table 86 Accessories Market Size for Guide Wires, By Region,2012-2019 ($Million)
  • Table 87 Accessories Market Size for Guide Wires, By Region, 2012-2019 (No. of Thousand Units)
  • Table 88 North America: Accessories Market Size for Guide Wires, By Country, 2012-2019 ($Million)
  • Table 89 Accessories Market Size for Balloon Inflation Devices, By Region, 2012-2019 ($Million)
  • Table 90 Accessories Market Size for Balloon Inflation Devices, By Region, 2012-2019 (No. of Thousand Units)
  • Table 91 North America: Accessories Market Size for Balloon Inflation Devices, By Country, 2012-2019 ($Million)
  • Table 92 Interventional Cardiology & Peripheral Vascular Devices Market Size, By Region, 2012-2019 ($Million)
  • Table 93 North America: Interventional Cardiology & Peripheral Vascular Devices Market Size, By Country, 2012-2019 ($Million)
  • Table 94 North America: Interventional Cardiology & Peripheral Vascular Devices Market Size, By Product, 2012-2019 ($Million)
  • Table 95 North America: Angioplasty Balloons Market Size, By Type, 2012-2019 ($Million)
  • Table 96 North America: Angioplasty Stents Market Size, By Type,2012-2019 ($Million)
  • Table 97 North America: Catheters Market Size, By Type, 2012-2019 ($Million)
  • Table 98 North America: EVAR Stent Grafts Market Size, By Type,2012-2019 ($Million)
  • Table 99 North America: IVC Filters Market Size, By Type, 2012-2019 ($Million)
  • Table 100 North America: Plaque Modification Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 101 North America: Hemodynamic Flow Alteration Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 102 North America: Accessories Market Size, By Type, 2012-2019 ($Million)
  • Table 103 U.S.: Interventional Cardiology & Peripheral Vascular Devices Market Size, By Product, 2012-2019 ($Million)
  • Table 104 U.S.: Angioplasty Balloons Market Size, By Type, 2012-2019 ($Million)
  • Table 105 U.S.: Angioplasty Stents Market Size, By Type, 2012-2019 ($Million)
  • Table 106 U.S.: Catheters Market Size, By Type, 2012-2019 ($Million)
  • Table 107 U.S.: EVAR Stent Grafts Market Size, By Type, 2012-2019 ($Million)
  • Table 108 U.S.: IVC Filters Market Size, By Type, 2012-2019 ($Million)
  • Table 109 U.S.: Plaque Modification Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 110 U.S.: Hemodynamic Flow Alteration Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 111 U.S.: Accessories Market Size, By Type, 2012-2019 ($Million)
  • Table 112 Canada: Interventional Cardiology & Peripheral Vascular Devices Market Size, By Product, 2012-2019 ($Million)
  • Table 113 Canada: Angioplasty Balloons Market Size, By Type, 2012-2019 ($Million)
  • Table 114 Canada: Angioplasty Stents Market Size, By Type, 2012-2019 ($Million)
  • Table 115 Canada: Catheters Market Size, By Type, 2012-2019 ($Million)
  • Table 116 Canada: EVAR Stent Grafts Market Size, By Type, 2012-2019 ($Million)
  • Table 117 Canada: IVC Filters Market Size, By Type, 2012-2019 ($Million)
  • Table 118 Canada: Plaque Modification Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 119 Canada: Hemodynamic Flow Alteration Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 120 Canada: Accessories Market Size, By Type, 2012-2019 ($Million)
  • Table 121 Europe: Interventional Cardiology & Peripheral Vascular Devices Market Size, By Product, 2012-2019 ($Million)
  • Table 122 Europe: Angioplasty Balloons Market Size, By Type,2012-2019 ($Million)
  • Table 123 Europe: Angioplasty Stents Market Size, By Type, 2012-2019 ($Million)
  • Table 124 Europe: Catheters Market Size, By Type, 2012-2019 ($Million)
  • Table 125 Europe: EVAR Stent Grafts Market Size, By Type, 2012-2019 ($Million)
  • Table 126 Europe: IVC Filters Market Size, By Type, 2012-2019 ($Million)
  • Table 127 Europe: Plaque Modification Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 128 Europe: Hemodynamic Flow Alteration Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 129 Europe: Accessories Market Size, By Type, 2012-2019 ($Million)
  • Table 130 Asia: Interventional Cardiology & Peripheral Vascular Devices Market Size, By Product, 2012-2019 ($Million)
  • Table 131 Asia: Angioplasty Balloons Market Size, By Type, 2012-2019 ($Million)
  • Table 132 Asia: Angioplasty Stents Market Size, By Type, 2012-2019 ($Million)
  • Table 133 Asia: Catheters Market Size, By Type, 2012-2019 ($Million)
  • Table 134 Asia: EVAR Stent Grafts Market Size, By Type, 2012-2019 ($Million)
  • Table 135 Asia: IVC Filters Market Size, By Type, 2012-2019 ($Million)
  • Table 136 Asia: Plaque Modification Devices Market Size, By Type,2012-2019 ($Million)
  • Table 137 Asia: Hemodynamic Flow Alteration Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 138 Asia: Accessories Market Size, By Type, 2012-2019 ($Million)
  • Table 139 RoW: Interventional Cardiology & Peripheral Vascular Devices Market Size, By Product, 2012-2019 ($Million)
  • Table 140 RoW: Angioplasty Balloons Market Size, By Type, 2012-2019 ($Million)
  • Table 141 RoW: Angioplasty Stents Market Size, By Type, 2012-2019 ($Million)
  • Table 142 RoW: Catheters Market Size, By Type, 2012-2019 ($Million)
  • Table 143 RoW: EVAR Stent Grafts Market Size, By Type, 2012-2019 ($Million)
  • Table 144 RoW: IVC Filters Market Size, By Type, 2012-2019 ($Million)
  • Table 145 RoW: Plaque Modification Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 146 RoW: Hemodynamic Flow Alteration Devices Market Size, By Type, 2012-2019 ($Million)
  • Table 147 RoW: Accessories Market Size, By Type, 2012-2019 ($Million)
  • Table 148 Regulatory Approvals, 2012-2015
  • Table 149 Acquisitions, 2012-2015
  • Table 150 New Product Launches, 2012-2015
  • Table 151 Agreements, Partnerships, and Collaborations, 2012-2015
  • Table 152 Other Developments, 2012-2015

List of Figures

  • Figure 1 Research Design
  • Figure 2 Top-Down Approach
  • Figure 3 Bottom-Up Approach
  • Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 5 Data Triangulation Methodology
  • Figure 6 Market Snapshot (2014 vs. 2019): Angioplasty Stents Segment to Dominate the Market From 2014 to 2019
  • Figure 7 Asia to Witness Highest Growth Rate in the IVUS/OCT Catheters Market From 2014 to 2019
  • Figure 8 Atherectomy Devices to Witness Fastest Growth From 2014 to 2019
  • Figure 9 North America to Dominate the Vascular Closure Devices Market, 2014-2019
  • Figure 10 Geographical Analysis of the Interventional Cardiology and Peripheral Vascular Devices Market
  • Figure 11 Interventional Cardiology and Peripheral Vascular Devices Market to Grow at High Rate
  • Figure 12 Drug-Eluting Stents Held the Largest Market Share Among Angioplasty Stents in 2014
  • Figure 13 U.S. Commanded One-Third of the Market Share in 2014
  • Figure 14 Atherectomy Segment to Grow at the Highest CAGR in the Plaque Modification Devices Market
  • Figure 15 Embolic Protection Devices Segment to Grow at Highest Rate Among Hemodynamic Flow Alteration Devices
  • Figure 16 IVUS/OCT Segment Will Continue to Lead the Catheters Market in the Forecast Period
  • Figure 17 Asia to Witness High Growth in the Interventional Cardiology and Peripheral Vascular Devices Market During Forecast Period
  • Figure 18 Interventional Cardiology and Peripheral Vascular Devices Market: Drivers, Restraints, Opportunities, and Challenges
  • Figure 19 Porter's Five Forces Analysis
  • Figure 20 Supply Chain Analysis
  • Figure 21 PTCA Procedures Will Dominate the Market in the Forecast Period
  • Figure 22 Drug-Eluting Balloons Will Dominate the Angioplasty Balloons Market in the Forecast Period
  • Figure 23 Drug-Eluting Stents to Dominate the Market During the Forecast Period
  • Figure 24 IVUS/OCT Market to Grow at Highest CAGR in the Forecast Period
  • Figure 25 Abdominal Aortic Aneurysms to Dominate the Global EVAR Stent Grafts Market During the Forecast Period
  • Figure 26 EVAR Stent Grafts Market in Asia to Grow at the Highest CAGR During the Forecast Period
  • Figure 27 Retrievable Filters Segment to Dominate Market in Forecast Period
  • Figure 28 Atherectomy Devices Market to Grow at Highest CAGR in the Forecast Period
  • Figure 29 Market for Embolic Protection Devices to Grow at Highest CAGR in the Forecast Period
  • Figure 30 Guide Wires Segment Dominates the Accessories Market
  • Figure 31 Geographic Snapshot (2014): Emerging Markets Hold Significant Growth Opportunities
  • Figure 32 Asia, an Attractive Market for Interventional Cardiology & Peripheral Vascular Devices
  • Figure 33 Increasing Demand for Interventional Cardiology and Peripheral Vascular Devices Driving Market Growth
  • Figure 34 Atherectomy Devices Will Dominate the Plaque Modification Devices Market in the U.S.
  • Figure 35 Angioplasty Stents Will Continue to Hold Largest Share in the European Market From 2014 to 2019
  • Figure 36 Asian Interventional Cardiology and Peripheral Vascular Devices Market Growing at the Highest CAGR (2014-2019)
  • Figure 37 Regulatory Approvals Was the Major Strategy Adopted By Players in the Interventional Cardiology and Peripheral Vascular Devices Market
  • Figure 38 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Key Player, 2014
  • Figure 39 Battle for Market Share: Regulatory Approvals Was the Key Strategy Adopted By Market Players
  • Figure 40 Product Benchmarking for Top 3 Market Players
  • Figure 41 Abbott Laboratories: Company Snapshot
  • Figure 42 B. Braun Melsungen AG: Company Snapshot
  • Figure 43 Boston Scientific Corporation: Company Snapshot
  • Figure 44 C.R. Bard: Company Snapshot
  • Figure 45 Johnson & Johnson: Company Snapshot
  • Figure 46 Medtronic, Inc.: Company Snapshot
  • Figure 47 Spectranetics International BV: Company Snapshot
  • Figure 48 St. Jude Medical, Inc.: Company Snapshot
  • Figure 49 Terumo Corporation: Company Snapshot
  • Figure 50 Volcano Corporation: Company Snapshot
Back to Top